<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>
<http://schema.org/SearchAction>
<http://www.genengnews.com/gen-news-highlights/disappointing-phase-iv-cardiovascular-outcomes-results-for-astrazeneca-bms-type-2-diabetes-drug/81248501/?kwrd=Metabolic%20Diseases>